The genes that underlie fatty liver disease: The harvest has begun

Hepatology

Volumn 49, Issue 2, 2009, Pages 692-694

  Weiskirchen, Ralf ^a   Wasmuth, Hermann E ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; KRUPPEL LIKE FACTOR 6; MEMBRANE PROTEIN; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING PROTEIN 3; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ETHNIC DIFFERENCE; FATTY LIVER; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEPATITIS; HUMAN; LIPID COMPOSITION; LIVER CIRRHOSIS; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 67449159240     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22800     Document Type: Short Survey

References (14)

1. Wieckowska A, McCullough AJ, Feldstein AE. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future. HEPATOLOGY 207;46:582-589.
2. Day CP. The potential role of genes in nonalcoholic fatty liver disease. Clin Liver Dis 2004;8:673-691.
3. Miele L, Beale G, Patman G, Nobili V, Leathart J, Grieco A, et al. The Kruppel-like factor 6 genotype is associated with fibrosis in non-alcoholic fatty liver disease. Gastroenterology 2008;135:282-291.
4. Hellerbrand C, Wasmuth HE. Genomewide genetic association studies in hepatology: The end of searching for the needle in the haystack? HEPATOLOGY 2007;46:1661-1663.
5. Wasmuth HE, Tag CG, Van de Leur E, Hellerbrand C, Mueller T, Berg T, et al. The Marburg I variant (G534E) of the factor VII-activating protease FSAP determines liver fibrosis in hepatitis C infection by reduced proteolysis of PDGF-BB. HEPATOLOGY. doi:10.1002/hep.22707.
6. Jonsson JR, Purdie DM, Clouston AD, Powell EE. Recognition of genetic factors influencing the progression of hepatitis C: Potential for personalized therapy. Mol Diagn Ther 2008;12:209-218.
7. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008;40:1461-1465.
8. Baulande S, Lasnier F, Lucas M, Pairault J. Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage. J Biol Chem 2001;276:33336-33344.
9. Liu YM, Moldes M, Bastard JP, Bruckert E, Viguerie N, Hainque B, et al. Adiponutrin: A new gene regulated by energy balance in human adipose tissue. J Clin Endocrinol Metab 2004;89:2684-2689.
10. Preiss D, Sattar N. Non-alcoholic fatty liver disease: An overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci 2008;115:141-150.
11. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. HEPATOLOGY 2004;40:1387-1395.
12. Yuan X, Waterworth D, Perry JR, Lim N, Song K, Chambers JC, et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet 2008;83:520-528.
13. Reiner AP, Barber MJ, Guan Y, Ridker PM, Lange LA, Chasman DI, et al. Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. Am J Hum Genet 2008;82:1193-1201.
14. Walker BA, Eze LC, Tweedie MC, Evans DA. The influence of ABO blood groups, secretor status and fat ingestion on serum alkaline phosphatase. Clin Chim Acta 1971;35:433-444.